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Abstract – 19 
1. The objective of this study was to evaluate the effect of ferric tyrosine on the 20 
reduction of Campylobacter spp. and zootechnical performance in broilers 21 
exposed to Campylobacter spp. using a natural challenge model to simulate 22 
commercial conditions. Additionally, the minimum inhibitory concentrations 23 
(MIC) of ferric tyrosine against common enteropathogens were evaluated.  24 
2. On day 0, 840 healthy male day-old birds (Ross 308) were randomly allocated to 25 
6 replicate pens of 35 birds and fed diets containing different concentrations of 26 
ferric tyrosine (0, 0.02, 0.05 and 0.2 g/kg) in mash form for 42 days. 27 
3. Overall, broilers fed diets containing ferric tyrosine showed significantly 28 
improved body weight at day 42 and weight gain compared to the control group. 29 
However, birds fed ferric tyrosine ate significantly more than the control birds so 30 
significant improvements in FCR were not observed. 31 
4. Microbiological analyses of caecal samples collected on day 42 of the study 32 
showed, per gram sample, 2-3 log10 reduction in Campylobacter spp. and 1 log10 33 
reduction in Escherichia coli in the groups fed diets containing ferric tyrosine 34 
compared to the control. 35 
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5. The MIC of ferric tyrosine was >400 mg/L for C. jejuni and >200 mg/L for E. coli 36 
and Salmonella enterica, indicating that ferric tyrosine does not exert 37 
antimicrobial activity. 38 
6. Collectively, these results show that birds fed ferric tyrosine grew faster and 39 
consumed more feed compared to the control birds indicating potential benefits 40 
of faster attainment of slaughter weight with no significant reduction on feed 41 
efficiency. Moreover, ferric tyrosine significantly reduces caecal Campylobacter 42 
spp. and E. coli indicating potential as a non-antibiotic feed additive to lower the 43 
risk of Campylobacter infections transmitted through the food chain.  44 
Keywords: Broilers, Campylobacter, control, ferric tyrosine, iron chelates 45 
  46 
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Introduction 47 
Campylobacteriosis is the most common human food-borne illness in the European Union 48 
(EU) (EFSA, 2017a) and along with other enteropathogenic bacteria such as Salmonella 49 
spp. and Escherichia coli (Chaveerach et al., 2004b; Santini et al., 2010; Hermans et al., 50 
2011), Campylobacter spp. pose a serious public health risk. Contaminated chicken meat 51 
is a major source of human infection (Freidman et al., 2004; Adak et al., 2005; Bull et al., 52 
2008), with ca. 200,000 reported cases of campylobacteriosis per year (EFSA, 2016). It 53 
is estimated that 75% of EU broiler meat samples are contaminated with Campylobacter 54 
spp. (EFSA, 2010). Campylobacter prevalence can be very high in poultry flocks, and is 55 
maintained along the food chain (EFSA, 2010, 2011). Reducing the number of 56 
contaminated carcasses entering the food chain will reduce the incidence of human cases 57 
of campylobacteriosis, hence Campylobacter control measures must be implemented on 58 
poultry farms to reduce human exposure (EFSA, 2011). It is estimated that reducing 59 
caecal Campylobacter numbers by 3 log10 CFU/g reduces the public health risk by 90% 60 
(Romero-Barrios et al., 2013). However, controlling Campylobacter on farms poses 61 
several serious challenges. A single bird infected with low numbers of Campylobacter 62 
can infect a whole flock (Stern et al., 2001). Furthermore, chickens appear asymptomatic 63 
meaning that infection can go undetected (EC, 2017). Strict biosecurity measures have 64 
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proven to be effective in excluding Campylobacter from housed flocks in northern Europe 65 
and the United Kingdom, but are difficult to maintain in the long-term under normal 66 
farming conditions (ACMSF, 2004; Bull et al., 2008). Antibiotics are no longer a viable 67 
option for control and are subject to global pressure to reduce use drastically, due to 68 
growing concerns about antimicrobial resistance (AMR). EFSA has recently reported that 69 
Campylobacter strains isolated from humans and pigs are resistant to ciprofloxacin and 70 
tetracyclines, critically important antibiotics for human use (EFSA, 2017b). Similar data 71 
were also reported for Salmonella spp. and E. coli isolates from fattening pigs, 72 
highlighting the growing problem of AMR. The EU banned the use of antibiotics as 73 
growth promoters in animal feeds in 2006 (EMA/EFSA, 2017) hence, there is an urgent 74 
need for alternatives to antibiotics that can protect farm animals and limit the 75 
establishment and growth of bacterial pathogens, in particular zoonotic micro-organisms. 76 
Various feed additives have been proposed to reduce Campylobacter colonization in 77 
chickens, including probiotics, prebiotics, organic acids, bacteriophages, bacteriocins, 78 
and plant-derivatives, some of which have shown promising results (Hermans et al., 2011; 79 
Guyard-Nicodème et al., 2015). Recently, in-feed chelated iron (III) complexes have 80 
shown to be effective against Campylobacter and other pathogenic bacteria in broilers 81 
(Khattak et al., 2018). However, in the study performed by Khattak et al., birds were 82 
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artificially challenged, so the purpose of the present study was to investigate whether iron 83 
chelates have comparable effects under more natural infection conditions. The aim of the 84 
present study was to evaluate the effect of ferric tyrosine (TYPLEX®, Akeso Biomedical 85 
Inc.) on broiler zootechnical performance and reduction of caecal Campylobacter spp. 86 
using birds naturally infected with Campylobacter spp. to simulate farm conditions. 87 
Additionally, the minimum inhibitory concentrations (MIC) of ferric tyrosine against 88 
common enteropathogens were evaluated to ascertain whether ferric tyrosine exerts 89 
antimicrobial activity.  90 
 91 
Material and Methods 92 
Experimental birds and diets 93 
The study protocol was approved by the Roslin Nutrition Ltd. Ethical Review Committee 94 
and the UK Food Standards Agency (FSA). The study birds were managed and handled 95 
in compliance with local animal welfare standards and Directive 2010/63/EU.  96 
A total of 1,100 pre-sexed, male day-old broilers (Ross 308) were purchased from a local 97 
commercial hatchery and delivered to the trial site (56.0092ºN, 2.8594ºW) in Aberlady, 98 
Scotland. The trial site was an experimental research facility with animal housing set up 99 
to simulate commercial conditions. Any chicks showing signs of ill-health, injury or in 100 
poor condition were excluded from the selection process. The poultry house was lit by 101 
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programmable artificial light. The standard lighting program was 23 hours of light per 102 
day, followed by 1-hour dark. Environmental conditions during the trial (temperature, 103 
humidity and ventilation rate) were automatically controlled and appropriate for the age 104 
of the broilers.  105 
 106 
Ferric tyrosine (TYPLEX®, Akeso Biomedical, Inc.) is an organo-iron complex of iron 107 
(III) complexed with L-tyrosine (4-hydroxyphenylalanine). The dietary treatments are 108 
summarised in Table 1. Control group (T1) was fed the basal diets (starter and grower). 109 
The treated groups received the basal diets supplemented with ferric tyrosine at 0.02 g/kg 110 
(T2), 0.05 g/kg (T3) or 0.20 g/kg feed (T4). Birds were fed a starter diet from 0 to 21 days 111 
and a grower diet from 21 to 41 days. All diets were formulated according to 112 
recommended specifications (NRC, 1996) then analysed (AOAC, 2007) for crude 113 
protein, ether extract, dry matter, iron and ash (Tables 2 and 3). Coloured tracers (Micro-114 
Tracers Inc., San Francisco) were added to ferric tyrosine at 10% w/w, to enable visual 115 
confirmation of ferric tyrosine content in feeds. Proximate analyses of feed samples 116 
confirmed that feed nutrients were within expected ranges. Diets did not contain any other 117 
added iron compounds, coccidiostats or veterinary antibiotics. Feed and water were 118 
offered ad libitum. 119 
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Study design 120 
On day 0, out of a pool of 1,100 birds, 840 healthy birds were randomly allocated to four 121 
treatment groups: Control (T1), ferric tyrosine at 0.02 g/kg feed (T2), 0.05 g/kg (T3) or 122 
0.20 g/kg feed (T4) with six replicate pens per group, each pen containing 35 birds, 123 
according to a randomised complete block design. The birds were weighed by pen on 124 
arrival and then on 21 and 42 days of trial. Individual bird body weight (BW) was 125 
calculated by dividing the average weight of the pen by the number of birds. Feed 126 
consumption and feed refusals were recorded by pen on day 21 and 42. Mortality/culls 127 
were recorded daily. Average pen weight gain (AWG), feed intake (AFI) and feed 128 
conversion rate (FCR, feed/gain) were calculated for periods 0-21, 22-42 and 0-42 days 129 
on trial. At study end (42 days on trial), five birds/pen were humanely euthanized and 130 
caecal samples were collected and sent for microbiology. The trial terminated after 42 131 
days and all birds were humanely euthanised by cervical dislocation and the carcasses 132 
destroyed. 133 
Campylobacter spp. challenge 134 
A natural Campylobacter challenge model was used whereby study birds were bedded on 135 
fresh wood shavings, over which litter from the previous batch of broilers was laid. This 136 
natural challenge model was developed at Roslin Nutrition. The natural challenge model 137 
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was selected to replicate as far as possible, a natural infection under commercial 138 
conditions. Litter samples from previous batches of birds taken from the barn used for 139 
this study had tested positive for Campylobacter spp. Furthermore, birds previously 140 
housed in this barn had tested positive for Campylobacter spp. on several occasions. 141 
Microbiology 142 
On day 42, five birds per pen were humanely euthanised by cervical dislocation. The 143 
caeca from each individual bird were removed and tied off to preserve caecal contents, 144 
placed in a pre-labelled zip-lock bag and immediately placed on dry ice. The birds were 145 
processed in descending order of ferric tyrosine concentration with the control birds 146 
processed last to reduce the likelihood of cross-contamination. Sterile equipment was 147 
used and changed between each treatment group. Latex gloves were worn by study staff 148 
responsible for the removal of the caeca and were changed between treatment groups. 149 
The samples were sent via courier to the microbiology laboratory for Campylobacter spp. 150 
and E. coli enumeration by conventional culture. Caeca were stored frozen (-80ºC) until 151 
analysis. Prior to analysis, the caecal samples were removed from the freezer and allowed 152 
to defrost. A sterile scalpel was used to cut off the blind end of both caecal sacks. From 153 
each caecal sack, 0.5 gram of caecal contents, in total 1g, was weighed into sterile 154 
Universal bottles, diluted with 2 ml sterile Maximum Recovery Diluent (MRD, Oxoid, 155 
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Basingstoke, UK), and mixed thoroughly.  This constituted the 1:2 dilution (w/v). Further 156 
serial dilutions were made in MRD and 10 µl of each dilution were inoculated on CCDA 157 
and Brilliance CampyCount Agar plates (Oxoid, Basingstoke, UK), incubated 158 
microaerophilically at 42°C for 24-48 hr and then assessed for the presence or absence of 159 
thermotolerant Campylobacter species. The individual caeca from five birds per pen were 160 
analysed in duplicate (i.e. two replicate samples analysed per bird). Plates of an 161 
appropriate dilution were selected and putative colonies enumerated. As a confirmatory 162 
measurement, two colonies from each presumptively positive plate were selected and sub-163 
cultured onto paired blood agar plates (Oxoid, Basingstoke, UK). These plates were 164 
incubated at 37°C for 48 hr, one plate aerobically, one plate microaerophilically. The 165 
presence of Campylobacter was indicated by a lack of growth aerobically and colonies 166 
with Campylobacter morphology that grow microaerophilically. In addition, Gram stains 167 
were carried out on all presumptively positive samples. As a further step, oxidase strips 168 
(Oxoid, Basingstoke, UK) were used to confirm that samples were oxidase positive 169 
(Cowan and Steel, 1965; Corry et al., 1995). The same series of samples were tested for 170 
presence and absence of E. coli using chromogenic plates (Oxoid, Basingstoke, UK) and 171 
incubated for 20 hr at 37°C, using the same procedure as reported for Campylobacter 172 
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enumeration. All results were expressed as colony forming units (CFU) per gram of 173 
caecal contents. 174 
In addition, Polymerase chain reaction (PCR) was conducted on five representative 175 
colonies isolated from CCDA plates from each treatment group to confirm the presence 176 
of C. jejuni vs. C. coli. The primer sets in the multiplex PCR target the identification of 177 
Campylobacter jejuni and Campylobacter coli based on the amplification of the two 178 
genes, mapA (589 bp) C. jejuni and ceuE C. coli (462 bp). In addition, a 16S primer 179 
(800bp) set was included as quality assurance of the DNA-preparation and analysis 180 
(internal control). Between 3-4 colony morphotypes from each treatment group were 181 
examined. To avoid false negatives three different concentrations of each isolate’s 182 
template were used for PCR amplification. 183 
 184 
Minimum inhibitory concentration assays (Growth inhibition studies with 185 
Campylobacter jejuni, Escherichia coli and Salmonella enterica) 186 
Ferric tyrosine was subjected to two digestive phases to mimic digestion in the broiler 187 
gut. Ferric tyrosine is poorly soluble and the digestive steps were included to enhance 188 
product solubility and bioavailability. The pepsin digestion phase was performed to 189 
mimic conditions in the acidic proventriculus and the pancreatin digestion phase to mimic 190 
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conditions in the neutral duodenum. In brief, 240 mg ferric tyrosine was suspended in 5 191 
ml of 50 mM Na-phosphate buffer pH 6.5. Then 2.25 ml of 150 mM HCl and 0.75 ml of 192 
activated pepsin (1 mg/ml) in 10 mM HCl were added; and the pH adjusted to pH 2.1. 193 
The resulting suspension was digested for 1 hr at 37 °C. Following the pepsin digestion 194 
phase, 4 ml of 150 mM NaHCO3, 2 ml of bovine bile (125 mg/ml in 150 mM NaHCO3) 195 
and 2 ml of porcine pancreatin (12.5 mg/ml in 150 mM NaHCO3) were added to the 196 
digested suspension and the pH was adjusted to 6.5 with NaOH. The suspension was then 197 
left to digest for 3 hr at 37 °C after which the total volume was adjusted to 20 ml. A 198 
positive control (PC) was prepared by following the steps described above, with no added 199 
ferric tyrosine. The two digests (PC digest and 20 mM ferric tyrosine digest) were 200 
sterilized by UV light before use in the MIC studies.  201 
 202 
For the MIC dilution study, C. jejuni strain DSM4688 grown in Müller-Hinton growth 203 
medium, and E. coli strain 156/97 F4+ and S. enterica serovar Typhimurium strain IR715 204 
both grown in Luria broth were added to 96-well microtitre plates (Merck, Germany) 205 
containing the ferric tyrosine digest at concentrations ranging from 25.5 to 408 mg/L for 206 
C. jejuni and 0.39 to 200 mg/L for E. coli and S. enterica, and the PC digest in dilutions 207 
corresponding to the amounts of digest added with the ferric tyrosine. The range of 208 
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concentrations selected were chosen to meet or exceed the practical doses used in feed. 209 
All plates were incubated at 38ºC. Plates containing C. jejuni were read after 24 hr by 210 
measuring fluorescence with a Perkin Elmer multimode plate reader after rendering 211 
bacterial cells fluorescent with SYBR Green dye (Sigma Aldrich, Darmstadt, Germany). 212 
Plates containing E. coli and S. enterica were read at 4 and 20 hr. Turbidity was measured 213 
using a spectrophotometer at a wavelength 600 nm. The MIC value was defined as the 214 
lowest product concentration that yields >50% reduction in growth obtained in cultures 215 
with no added test product. 216 
 217 
Statistical analyses 218 
The pen was considered the experimental unit for zootechnical and microbiological data. 219 
The arithmetic means of body weight, average daily gain, average feed intake and feed 220 
conversion rate were calculated per pen. The bacterial counts were transformed to log10 221 
prior to analysis. Zootechnical and microbiological data were analysed by one-way 222 
analysis of variance (ANOVA) using the General Linear Model (GLM) procedure in 223 
Unistat (Unistat Ltd., Version 6.5) according to the following model: Yi = μ + αi + εi, 224 
where Yi was the dependent variable, μ was the overall mean, αi was the effect of 225 
treatment, and εi was the residual error. For zootechnical and microbiological data, 226 
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significant differences were declared at P≤0.05, while near significant trends were 227 
considered for 0.05<P≤0.10. Arithmetic means were separated by Tukey’s post-hoc 228 
comparison test. Results are reported as arithmetic means, the treatment probability (P) 229 
and the pooled standard error of the mean (SEM). If Campylobacter counts are randomly 230 
distributed among individual birds and pens, the counts obtained should follow a Poisson 231 
distribution, where variance equals the mean. If variance exceeds the mean this indicates 232 
overdispersion and demonstrates that the counts are not homogenous. The distribution of 233 
caecal Campylobacter spp. and E. coli counts were assessed for overdispersion by 234 
multiplying the variance to mean ratio by the number of degrees of freedom, and 235 
comparing the results with the chi-square distribution (Bliss and Fisher, 1953). 236 
Overdispersion was confirmed when P<0.05). 237 
 238 
Results  239 
The effect of ferric tyrosine on broiler zootechnical performance during each study period 240 
is summarised in Table 4. The mortality rate (including culled birds) was low and there 241 
were no significant differences in mortality between treatment groups (T1, 6/210 (2.9%); 242 
T2, 4/210 (1.9%); T3, 4/210 (1.9%); T4, 6/210 (2.9%)). The majority (13/20) of birds 243 
were culled early in the study as poor or non-starters/small birds. During the first study 244 
period (0 to 21 days on trial), broilers fed diets supplemented with ferric tyrosine (T2, T3 245 
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and T4) weighed significantly more at day 21 (+110 g, +130 g, +63 g; 630, 650, 583 vs. 246 
520 g; P0.001, P0.001, P=0.002, respectively), and gained significantly more weight 247 
(+110 g. +130 g, +63 g; 588, 608, 541 vs. 478 g; P0.001, P0.001, P=0.003, 248 
respectively) compared to broilers fed the T1 Control diet. No significant differences were 249 
noted in feed efficiency (Table 4). Similarly, during the second study period (22 to 42 250 
days on trial), broilers fed T2, T3 and T4 diets weighed significantly more at study end 251 
(+213 g, +190 g, +180 g; 2,081, 2,052, 2,048 vs. 1,868 g; P=0.002, P=0.008, P=0.009; 252 
respectively) and broilers fed T2 and T3 diets consumed significantly more feed (+263 g, 253 
+219 g; 2,751, 2,707 vs. 2,488 g; P=0.005, P=0.021; respectively) compared to broilers 254 
fed the T1 Control diet. Broilers fed the T3 diet presented a significantly higher feed 255 
conversion ratio (1.934 vs. 1.845, 1.827 g; P=0.014, P=0.003; respectively) compared to 256 
broilers fed the T1 Control diet and the T4 diet. In addition, broilers receiving the T4 diet 257 
tended to gain more weight (+117 g; 1,465 vs. 1,348 g; P=0.062; respectively) and to eat 258 
more (+187 g; 2,675 vs. 2,488 g; P=0.057; respectively) compared to broilers fed the T1 259 
Control diet. During the overall study period (0 to 42 days on trial) broilers fed the diets 260 
containing ferric tyrosine (T2, T3 and T4) gained significantly more weight (+212 g, +182 261 
g, +179 g; 2,039, 2,009, 2,006 vs. 1,827 g; P=0.002, P=0.008, P=0.009; respectively) and 262 
ate significantly more feed (+385 g, +385 g, +258 g; 3,609, 3,609, 3,482 vs. 3,224 g; 263 
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P0.001, P0.001, P=0.027; respectively) compared to broilers fed the T1 Control diet. 264 
No significant differences in feed efficiency were noted between the groups 265 
supplemented with ferric tyrosine and the T1 Control group. 266 
Microbiological counts from the caecal samples collected on day 42 are summarised in 267 
Table 5. The results showed a significant reduction in Campylobacter spp. in birds fed 268 
T3 and T4 diets compared to the birds fed the T1 Control diet (1.8 log10 reduction, 269 
P<0.001 and 2.5 log10 reduction, P<0.001, respectively, Table 5 and Figure 1a) when 270 
samples were grown on CCDA medium. Moreover, when samples were grown on 271 
Brilliance medium, Campylobacter spp. counts were significantly reduced in birds fed 272 
T2, T3 and T4 diets compared to the birds that were fed the T1 Control diet (1.2 log10 273 
reduction, P=0.043; 2.4 log10 reduction, P=0.001 and 3.1 log10 reduction, P<0.001, 274 
respectively, Table 5 and Figure 1b). There was a near-significant trend towards reduced 275 
E. coli counts in broilers fed the T4 diet compared to broilers fed the T1 Control diet (1.3 276 
log10 reduction, P=0.083, respectively, Table 5 and Figure 1c). All individual birds in T1 277 
tested positive for Campylobacter spp. and E. coli. Furthermore, Figure 1 shows the 278 
distribution of the counts for each treatment groups and demonstrates that all pens in T1 279 
were positive for Campylobacter spp. and E. coli. Additionally, all birds from T2 and T3 280 
had positive Campylobacter counts and only two birds from T4, each from different pens 281 
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(pen 4 and pen 13), had a negative Campylobacter count. However, the other birds tested 282 
from pen 4 & 13 were positive. Analysis of the distribution of the counts in T1 birds and 283 
T1 pens showed that the distribution conformed to a Poisson distribution, where the mean 284 
and variance are equal, indicating that the counts were homogenous among control birds 285 
and pens and there was no significant overdispersion of counts. In comparison, significant 286 
overdispersion was observed for the Campylobacter counts from Brilliance media for T3 287 
and T4 (P=0.03 and P<0.001, respectively). 288 
 289 
Results from the PCR confirmed the presence of C. jejuni and C. coli.  290 
 291 
The MIC value for C. jejuni was >400 mg/L (Table 6) and >200 mg/L for E. coli and S. 292 
enterica (Table 7). After 24 hr incubation, C. jejuni fluorescence increased by 29% when 293 
exposed to the PC digest at a dilution corresponding to 408 mg/L ferric tyrosine and 294 
increased by 13% when exposed to ferric tyrosine digest at 408 mg/L (Table 6). After 20 295 
hr incubation, the turbidity of E. coli decreased by 61% with PC digest dilution 296 
corresponding to digest provided with 49.9 mg/L ferric tyrosine digest and decreased by 297 
14% at 200 mg/L ferric tyrosine digest (Table 7). Similarly, S. enterica turbidity 298 
decreased by 37% after 20 hr incubation when exposed to the PC digest at 200 mg/L, and 299 
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turbidity increased by 5% after 20 hr when exposed to 200 mg/L ferric tyrosine (Table 300 
7).  301 
Discussion 302 
Here, the effects of ferric tyrosine on broiler zootechnical performance and caecal 303 
Campylobacter spp. and E. coli were evaluated, along with an investigation into the MIC 304 
of ferric tyrosine against C. jejuni, E. coli and S. enterica. The results from the present 305 
study show that ferric tyrosine when administered in the feed of broilers, significantly 306 
reduced caecal Campylobacter spp. (T3 and T4), reduced E. coli counts (T4), and 307 
significantly improved weight gain at day 42, but did not affect FCR. Under the 308 
conditions of this study, ferric tyrosine added to diets at 0.02 g/kg, 0.05 g/kg and 0.20 309 
g/kg led to a 1.2 log10, 2.4 log10 and 3.1 log10 CFU/g reduction in caecal Campylobacter 310 
spp. counts, respectively, when samples were grown on Brilliance media. These results 311 
agree with those from a recent study that evaluated ferric tyrosine in broiler diets (Khattak 312 
et al., 2018). In that study, the authors reported caecal Campylobacter reductions of 0.8 313 
log10, 1.9 log10 and 2.0 log10 CFU/g in birds fed ferric tyrosine at 0.02 g/kg, 0.05 g/kg and 314 
0.20 g/kg, respectively. A recent quantitative microbial risk assessment (QMRA) 315 
estimated that reducing caecal colonisation of birds at flock level by 2 log10 or 3 log10 316 
CFU/g could reduce the incidence of human campylobacteriosis attributed to 317 
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contaminated broiler meat by 76% and 90%, respectively (Romero-Barrios et al., 2013). 318 
Another earlier QMRA estimated that the incidence of disease in humans could be 319 
reduced by 48%, 85% and 96% if carcass contamination with Campylobacter can be 320 
reduced by 1, 2 or 3 log10 CFU/g, respectively (Messens et al., 2007). According to these 321 
figures, ferric tyrosine added to diets at 0.02 g/kg, 0.05 g/kg and 0.20 g/kg meets the 322 
thresholds outlined in the two QMRAs, indicating that this product could be useful for 323 
reducing the burden of Campylobacter on poultry farms, which may lead to a reduction 324 
in broiler meat contamination at slaughter. Slight differences were observed in counts 325 
when Campylobacter was grown on CCDA (Campylobacter Blood Free Selective Agar) 326 
media, which can be used for the isolation of Campylobacter jejuni, Campylobacter coli 327 
and Campylobacter lari. Brilliance CampyCount Agar is a medium specifically designed 328 
for accurate, specific and easy enumeration of Campylobacter jejuni and Campylobacter 329 
coli from poultry. It is a transparent medium on which Campylobacter produce distinct 330 
dark red colonies, making identification and counting significantly easier than on 331 
traditional charcoal or blood containing agar. PCR analysis confirmed the presence of C. 332 
jejuni and C. coli. In addition to the reduction of caecal Campylobacter, a reduction in 333 
caecal E. coli was also noted. Caecal E. coli counts were reduced by 1.0 log10, 0.7 log10 334 
and 1.3 log10 CFU/g in birds fed ferric tyrosine at 0.02 g/kg, 0.05 g/kg and 0.20 g/kg feed, 335 
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respectively. These results agree with those of Khattak et al. (2018) who reported 336 
reductions of 0.6 log10, 0.8 log10 and 1.2 log10 CFU/g, respectively. It has been suggested 337 
that E. coli infection is established more easily in birds infected with Campylobacter (Bull 338 
et al., 2008) and an epidemiological study reported increased E. coli in chicken carcasses 339 
infected with Campylobacter (Duffy et al., 2014). Moreover, translocation of E. coli to 340 
the liver, spleen and caecum increases in birds infected with C. jejuni (Awad et al., 2016). 341 
This evidence would suggest that Campylobacter infection may positively influence the 342 
establishment of other pathogenic microbial populations, which could have serious 343 
implications for public health. In addition, the emergence of antibiotic resistance to 344 
Campylobacter spp. in humans and animals underlines the need for non-antibiotic 345 
alternatives to aid Campylobacter control on farms.  346 
 347 
In this study, a natural challenge model was used, whereby study birds were housed in a 348 
barn that had housed broilers that previously tested positive for Campylobacter spp. on 349 
several occasions, and were placed in in pens containing dirty litter from an earlier study, 350 
in which birds had tested positive for campylobacters. This study design did not quantify 351 
the level of infection before or during the study. However, on day 42, all caecal samples 352 
collected from control birds tested positive for Campylobacter spp., and the counts 353 
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followed a Poisson distribution indicating that the infection was homogenous among 354 
individual birds and pens. Furthermore, as the layout of pens followed a randomised block 355 
design, it is assumed that all pens were exposed to a similar level of Campylobacter spp. 356 
challenge. It has been shown that a single bird harbouring low numbers of Campylobacter 357 
can infect a whole flock, (Stern et al., 2001) and that once a flock becomes Campylobacter 358 
positive, the surrounding environment becomes widely contaminated (Herman et al., 359 
2003) and contamination can persist for several weeks (Johnsen et al., 2006).  360 
 361 
The MIC results presented in this study show that ferric tyrosine does not exert 362 
antimicrobial activity against the strains of C. jejuni, E. coli and S. enterica tested. MICs 363 
of >400 mg/L and >200 mg/L were reported for C. jejuni and E. coli and S. enterica, 364 
respectively, which are much higher than MIC thresholds used to monitor antimicrobial 365 
susceptibility and resistance. Furthermore, effective antimicrobials inhibit or kill 366 
Campylobacter spp. at low concentrations. According to recent guidelines, cut-off values 367 
for erythromycin, tetracycline and ciprofloxacin against Campylobacter jejuni are ≤4 368 
mg/L, ≤2 mg/L and ≤0.5 mg/L, respectively, while the cut-off values for ampicillin, 369 
ciprofloxacin and colistin when tested against Salmonella spp. and E. coli are ≤8 mg/L, 370 
≤0.06 mg/L and ≤2 mg/L, respectively (ECDC, 2016). This study has shown that ferric 371 
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tyrosine does not inhibit or kill Campylobacter spp. at concentrations up to 400 mg/mL, 372 
which is much higher than the ferric tyrosine concentration in the feed or broiler gut. 373 
Hence, these results indicate that ferric tyrosine does not exhibit classic antibiotic activity 374 
at up to 400 mg/mL.  375 
 376 
Significant improvements in final body weight and weight gain were observed in the birds 377 
fed ferric tyrosine in comparison to the birds fed the control diet. Similar results were 378 
observed in the study conducted by Khattak et al. (2018). C. jejuni infection can 379 
significantly impair the growth performance of poultry (Awad et al., 2014a,) and a highly 380 
significant negative association between Campylobacter and feed efficiency has been 381 
reported (Sparks, 2016). Campylobacter infection downregulates the gene expression of 382 
various carrier proteins responsible for the absorption of nutrients (Awad et al., 2014b), 383 
leading to decreased nutrient adsorption and reduced growth performance.  384 
 385 
Aspects of Campylobacter pathogenesis remain poorly understood, particularly 386 
molecular host-pathogen interactions. Human histo-blood group antigens (BgAgs) are 387 
often targeted by mucosal organisms to aid adherence prior to invasion. The BgAgs-388 
binding adhesins of C. jejuni have been identified as the major subunit protein of the 389 
23 
 
flagella (FlaA) and the major outer membrane protein (MOMP) (Mahdavi et al., 2014). 390 
MOMP is a member of the trimeric bacterial porin family that assists the mucosal 391 
adhesion and invasion of C. jejuni (Mahdavi et al., 2014). Porins are involved in the 392 
uptake of nutrients through the outer membrane by passive diffusion along concentration 393 
gradients (Ferarra et al., 2016). MOMP is also able to bind to multiple host cell 394 
membranes by promoting biofilm formation and auto-aggregation. The actual mode of 395 
action of ferric tyrosine is unknown, but some bacteria use specific outer membrane 396 
receptors to uptake ferric iron. It is thought that ferric tyrosine may be able to bind to 397 
MOMP and block the interaction of MOMP on the surface of Campylobacter with the 398 
BgAgs of the gastrointestinal epithelial cells. As a result, it prevents Campylobacter 399 
colonization of the avian gut by reducing biofilm formation. A recent study has 400 
demonstrated that ferric tyrosine inhibits biofilm formation in vitro (Khattak et al., 2018), 401 
which supports the assumed mode of action. 402 
 403 
Campylobacter remains a real threat to public health. With prophylactic administration 404 
of antibiotics at farm level no longer a viable control option due to increasing antibiotic 405 
resistance, there is a critical need to find non-antibiotic alternatives that can be used in 406 
conjunction with on-farm biosecurity measures to reduce Campylobacter colonisation of 407 
24 
 
poultry flocks. In conclusion, the results from the present study illustrate that ferric 408 
tyrosine can significantly reduce caecal Campylobacter spp. and E. coli and improve bird 409 
weight gain, indicating that this feed additive may contribute to control of Campylobacter 410 
spp. under commercial poultry production conditions. 411 
  412 
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Table 1. Experimental diets 535 
Treatment 
Ferric tyrosine, 
g/kg feed 
Microtraced1 
Ferric tyrosine 
g/kg feed 
T1 Control – 0 g/kg 0 
T2 T1 + 0.02 g/kg feed 0.0222 
T3 T1 + 0.50 g/kg feed 0.0552 
T4 T1 + 0.20 g/g/feed 0.2202 
11 g of microtracer contains 60,000 violet graphite particles 
2Microtracers at 10% in test products 
 536 
  537 
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Table 2. Feed composition and calculated analyses 538 
Ingredients (%) 
Starter Mash 
1-21 days of age 
Grower Mash 
22-42 days of age 
Wheat 69.862 67.354 
Barley - 7.5 
Soybean meal, 48% CP 23.4 21.4 
Sodium bicarbonate 0.13 0.22 
Fishmeal 66% 2.5 - 
Soy oil 1.3 1.4 
L-lysine HCl 0.128 0.175 
DL-methionine 0.123 0.164 
Choline chloride 0.067 0.067 
Dicalcium phosphate 0.13 0.32 
Calcium carbonate 1.74 0.74 
Sodium chloride 0.12 0.16 
Minerals and vitamins1 0.5 0.5 
Total 100 100 
Calculated analyses (%, unless specified differently) 
ME Broiler, MJ/kg 11.526 12.346 
Crude protein  21 19 
Crude fibre 2.73 2.914 
Ash 5.796 4.571 
Dry matter 72.97 77.503 
Crude fat 3.0 3.0 
Lysine 1.18 1.050 
Methionine 0.45 0.438 
Methionine + cysteine 0.797 0.766 
Threonine 0.75 0.661 
Tryptophan 0.259 0.237 
Calcium 1.102 0.651 
Sodium 0.126 0.142 
1Supplies per kg feed: Vit A: 0.010 MIU; Vit D3: 0.005MIU; Vit E: 50mg; Vit K3: 3 mg; 
Vit B1: 2.0 mg; Vit B2: 7 mg; Vit B6: 5 mg; Vit B12: 15 g; Folic acid: 1.0 mg;  
Biotin: 0.2 mg; Pantothenic acid: 15 mg; 3a315 niacinamide: 50 mg; Mo 0.5 mg 
Mn: 100 mg; Zn: 80 mg; I: 1.0 mg; Cu: 10 mg; Se: 0.20 mg, Fe: 267 mg 
 539 
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Table 3. Analysed values of experimental diets 541 
 542 
Sample Diet 
Ferric 
tyrosine, 
g/kg 
Moisture 
(%) 
Crude 
protein 
(%) 
Ether 
extract 
(%) 
Ash 
(%) 
Fe 
(mg/kg) 
Ferric tyrosine-
microtracer 
(% recovery1) 
Calculated 
ferric 
tyrosine 
content 
(g/kg) 
T1  Starter 0 11.6 20.4 3.1 5.5 125 NA NA 
T2  0.02 11.5 20.3 2.9 5.4 189 131 0.026 
T3  0.05 11.3 20.6 2.9 5.5 198 118 0.059 
T4  0.20 11.3 20.5 2.9 5.3 196 107 0.214 
T1  Grower 0 11.9 19.1 3.2 4.2 171 NA NA 
T2  0.02 11.9 18.7 3.0 4.2 159 98 0.020 
T3  0.05 11.9 18.7 3.0 4.7 185 85 0.043 
T4  0.20 11.5 19.1 3.0 4.4 166 81 0.162 
NA – Not applicable; 1Calculated ferric tyrosine = % recovery of microtracer x ferric tyrosine dose  543 
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Table 4. Effect of dietary addition of ferric tyrosine on broiler zootechnical performance 544 
parameters for each study period. 545 
 546 
Parameter Treatment SE Treatment P-
value 
(ANOVA) 
T1 
0 g/kg  
ferric 
tyrosine 
T2 
0.02 g/kg  
ferric 
tyrosine 
T3 
0.05 g/kg  
ferric 
tyrosine 
T4 
0.20 g/kg  
ferric 
tyrosine 
BW 1 d (g) 41.81 42.00 42.48 42.19 0.135 0.364NS 
BW 21 d, (g) 520a 630c 650c 583b 11.6 0.001 
BW 42 d (g) 1,868a 2,081b 2,052b 2,048b 24.0 0.001 
AWG 1-21 d (g) 478a 588c 608c 541b 11.5 0.001 
AWG 22-42 (g) 1,348x 1,451xy 1,401xy 1,465y 17.2 0.055 
AWG 1-42 d (g) 1,827a 2,039b 2,009b 2,006b 24.0 0.002 
AFI 1-21 d (g) 737a 859bc 901c 807ab 16.5 0.001 
AFI 22-42 (g) 2,488a,x 2,751b 2,707b 2,675ab,y 30.8 0.005 
AFI 1-42 d (g) 3,224a 3,609b 3,609b 3,482b 42.8 0.001 
FCR 1-21 d (g) 1.539 1.462 1.484 1.488 0.0138 0.240NS 
FCR 22-42 (g) 1.845a 1.898ab,y 1.934b 1.827a,x 0.0124 0.002 
FCR 1-42 d (g) 1.765xy 1.771xy 1.798y 1.736x 0.0087 0.083 
Results show least square mean of 6 replicate pens. Nº replicates/treatment = 6 pens of 35 male birds/ treatment; Means 547 
separated by Tukey Test. SE = Standard error; BW = mean bird body weight; AWG = mean pen weight gain; AFI = 548 
mean pen feed intake; FCR = feed/gain; NS – not significant. Values in same column with no common abc superscript 549 
are significantly different (P0.05); Values in same column with no common xy superscript exhibit a near-significant 550 
trend (0.05<P0.10). Text in bold = significant result (P≤0.05); text in italics = near-significant trend (0.05<P0.10).  551 
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Table 5. Caecal Campylobacter spp. and E. coli counts at 42 days of age (log10 CFU/g) 552 
 553 
 554 
  555 
Treatment Dose g/kg 
Campylobacter spp. E. coli 
Caeca1 Caeca2 Caeca 
T1 Control 0 5.879c 4.799c 6.438y 
T2 Ferric tyrosine 0.02 4.989bc 3.621b 5.449xy 
T3 Ferric tyrosine 0.05 4.104ab 2.399a 5.736xy 
T4 Ferric tyrosine 0.20 3.366a 1.681a 5.118x 
SEM 0.1301 0.1448 0.1843 
Treatment P-value (ANOVA) 0.001 0.001 0.104 
Nº replicates = 6 replicate pens per treatment. Results show group least square mean of 6 replicate pens  
1 Caecal samples cultured on CCDA medium; 2 Caecal samples cultured on Brilliance medium, SEM = 
standard error of the mean. 
Values in same column with no common abc superscript are significantly different (P0.05) 
Values in same column with no common xy superscript exhibit a near-significant trend (0.05<P0.10) 
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Table 6. Effect of ferric tyrosine on the growth of Campylobacter jejuni DSM4688 and 556 
minimum inhibitory concentrations (MIC). 557 
 558 
Bacterium 
Ferric tyrosine 
(mg/L) 
Fluorescence after 24h incubation (x10-6) 
MIC 
(mg/L) 1 Positive control digest Ferric tyrosine digest 
C. jejuni 
25.5 2.58 2.38 
> 400 
51 2.90 3.75 
102 2.82 2.83 
204 3.27 3.41 
408 3.34 2.68 
 559 
1 No product was added to the positive control digest. The concentration shown indicates that dilution of 560 
the digest was the same as that used for the corresponding ferric tyrosine digest.  561 
  562 
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Table 7. Effect of ferric tyrosine on the growth of Escherichia coli 156/97 F4+ and 563 
Salmonella enterica serovar Typhimurium strain IR715 and the minimum inhibitory 564 
concentrations (MIC). 565 
 566 
Bacterium 
Ferric 
tyrosine 
(mg/L) 
Turbidity at 600 nm 
MIC (mg/L) 1Positive control digest Ferric tyrosine digest 
4h growth  20h growth 4h growth 20h growth 
E. coli 
0.39 0.20 0.38 0.19 0.36 
> 200 
0.78 0.17 0.38 0.18 0.34 
1.56 0.16 0.35 0.18 0.36 
3.12 0.15 0.32 0.19 0.36 
6.24 0.15 0.29 0.20 0.37 
12.5 0.15 0.23 0.20 0.37 
24.9 0.16 0.20 0.20 0.37 
49.9 0.14 0.15 0.20 0.36 
99.8 0.15 0.15 0.19 0.33 
200 0.17 0.15 0.18 0.31 
S. enterica 
0.39 0.25 0.65 0.28 0.61 
> 200 
0.78 0.26 0.64 0.27 0.61 
1.56 0.25 0.65 0.28 0.61 
3.12 0.22 0.62 0.28 0.62 
6.24 0.24 0.63 0.28 0.62 
12.5 0.25 0.61 0.28 0.62 
24.9 0.25 0.61 0.27 0.63 
49.9 0.26 0.60 0.27 0.62 
99.8 0.26 0.49 0.24 0.61 
200 0.25 0.41 0.23 0.64 
1 No product was added with the positive control digest. The concentration shown indicates that dilution 567 
of the digest was the same as that used for the corresponding ferric tyrosine digest.  568 
 569 
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Figure captions 571 
 572 
Figure 1. Boxplots showing the distribution of caecal Campylobacter spp. and E. coli 573 
counts at Day 42: a. Caecal Campylobacter spp. counts (log10 CFU/g) grown on CCDA 574 
media, b. Caecal Campylobacter spp. counts (log10 CFU/g) grown on Brilliance media, 575 
c. Caecal E. coli counts (log10 CFU/g) grown on chromogenic media 576 
 577 
